🇺🇸 ARWR — Arrowhead Pharmaceuticals, Inc.

Salud Compra fuerte
← Volver

Precio actual

61,65 USD

Máx. histórico

2.925,00

12011 días

Split 1:10 del 17/11/2011

Caída desde máximo

-97,89%

Rango 52 semanas

37,06 – 95,49

Variación hoy

+3,56%

Cierre anterior

59,53

Rango de hoy

59,06 – 61,99

Volumen hoy

1.487.357

Peor caída histórica

-99,96%

16/12/1993 → 16/12/2016

Aún sin recuperar

Volatilidad anualizada ⓘ

231,86%

Información
Nombre completo
Arrowhead Pharmaceuticals, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
711
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
107,71 USD (puede no estar actualizado)
Primera cotización
16/12/1993
Precio actualizado
hace 1 hora
Sobre la empresa

Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. Its pipeline includes Plozasiran to reduce production of apolipoprotein C-III in Phase 3 studies; Zodasiran to reduce production of angiopoietin-like protein 3 in Phase 3 clinical trials; ARO-DIMER-PA, a dual functional RNAi molecule in a Phase 1/2a clinical trials; and ARO-PNPLA3, an investigational RNAi therapeutic in Phase 1 clinical trials. The company also develops ARO-INHBE, to reduce the hepatic expression of the INHBE gene and its secreted gene product, Activin E in Phase 1/2a clinical trials; ARO-ALK7 to silence adipocyte expression of the ACVR1C gene in Phase 1/2a clinical trials; ARO-RAGE to reduce production of the receptor for advanced glycation end products in Phase 1/2a clinical trials; and ARO-MAPT, an investigational RNAi-based therapy. In addition, it is developing ARO-C3 to reduce production of C3 in Phase 1/2a clinical trials; and ARO-CFB to reduce hepatic expression of CFB in a Phase 1/2a clinical trials. The company has collaboration and license Agreements with Glaxosmithkline Intellectual Property (No. 3) Limited; Takeda Pharmaceutical Company Limited; Amgen Inc.; and Sarepta Therapeutics, Inc. Arrowhead Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Pasadena, California.

Splits Registrados en el histórico de precios
Fecha Ratio
17/11/2011 1:10
15/01/2004 1:65
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
29/08/2022 39,08 40,53 38,90 39,22 -2,10% 4,17% 425.900
26/08/2022 42,62 42,68 39,96 40,06 -5,98% 6,38% 611.300
25/08/2022 43,22 43,65 41,94 42,61 -0,33% 3,95% 520.000
24/08/2022 41,35 43,12 40,98 42,75 +3,71% 5,18% 962.400
23/08/2022 41,20 41,89 40,21 41,22 +0,27% 4,08% 1.056.500
22/08/2022 41,88 42,94 40,77 41,11 -3,52% 5,18% 905.300
19/08/2022 43,33 44,04 42,14 42,61 -3,18% 4,37% 562.200
18/08/2022 45,61 46,12 43,02 44,01 -4,08% 6,79% 691.200
17/08/2022 46,83 47,13 45,71 45,88 -3,67% 3,03% 464.400
16/08/2022 48,00 48,17 46,75 47,63 -1,41% 2,96% 468.700
15/08/2022 47,02 48,48 46,50 48,31 +2,16% 4,21% 518.600
12/08/2022 46,16 47,90 46,06 47,29 +3,64% 3,99% 603.800
11/08/2022 46,96 48,08 45,17 45,63 -2,83% 6,20% 571.300
10/08/2022 46,46 47,02 45,75 46,96 +3,32% 2,73% 575.100
09/08/2022 45,85 46,84 44,90 45,45 -3,34% 4,23% 834.800
08/08/2022 46,52 47,64 45,28 47,02 +2,31% 5,08% 1.074.700
05/08/2022 44,41 46,40 43,61 45,96 -0,37% 6,28% 1.230.500
04/08/2022 44,38 46,54 44,34 46,13 +3,99% 4,96% 980.100
03/08/2022 44,00 45,32 43,46 44,36 +5,57% 4,23% 1.154.300
02/08/2022 41,34 43,20 41,34 42,02 +0,60% 4,50% 475.200
01/08/2022 41,68 43,48 41,38 41,77 -1,79% 5,05% 620.600
29/07/2022 43,34 43,34 41,93 42,53 -2,81% 3,25% 536.200
28/07/2022 44,27 44,46 41,55 43,76 -1,24% 6,58% 649.600
27/07/2022 42,16 44,60 41,58 44,31 +5,90% 7,16% 767.700
26/07/2022 41,54 42,80 40,77 41,84 +0,36% 4,89% 535.200
25/07/2022 42,61 42,80 40,69 41,69 -2,30% 4,95% 715.300
22/07/2022 44,64 44,93 42,42 42,67 -3,87% 5,62% 721.800
21/07/2022 44,06 44,88 43,86 44,39 +0,57% 2,32% 458.800
20/07/2022 42,92 45,13 42,92 44,14 +3,45% 5,15% 809.500
19/07/2022 42,08 43,38 40,84 42,67 +3,39% 6,04% 696.500